Atossa reports Q3 2026 results, outlines CVR tied to future priority review voucherNov 10Quarterly updateAtossa Therapeutics, Inc.endoxifen
TerSera recalls Zoladex lot over cold-chain lapse; AstraZeneca's EMERALD-2 HCC trial completesOct 8Weekly roundup, 7 itemsAstraZenecaAZD7760Updated
Atossa reports Q2 2026 results, completes enrollment in EVANGELINE trialAug 7Quarterly updateAtossa Therapeutics, Inc.endoxifen